Malaria is a mosquito-borne infectious disease of humans and other animals caused by parasitic protozoans (a type of unicellular microorganism) of the genus Plasmodium. Commonly, the disease is transmitted via a bite from an infected female Anopheles mosquito, which introduces the organisms from its saliva into a person’s circulatory system. In the blood, the protists travel to the liver to mature and reproduce. Malaria causes symptoms that typically include fever and headache which in severe cases can progress to coma or death. The disease is widespread in tropical and subtropical regions in a broadband around the equator, including much of Sub-Saharan Africa, Asia, and the Americans Five species of Plasmodium can infect and be transmitted by humans. The vast majority of deaths are caused by Plasmodium falciparum and Plasmodium vivax, while Plasmodium ovale and Plasmodium malariae cause a generally milder form of malaria that is rarely fatal. The result showed that prevalence of typhoid fever in both male and female are 9 (%) and 21 (21%) respectively. The distribution of this result was statistically significant (p<0.05; X2=4.745). The result showed that prevalence of typhoid fever in both male and female are 6 (6%) and 4 (4%) respectively. The distribution of this result was not statistically significant (p>0.05; X2=0.105). The result showed that prevalence of the co-infection in both male and female are 3 (3%) and 2 (2%) respectively. The distribution of this result was not statistically significant (p>0.05; X2=0.205). The result showed that co-infection was negatively correlated with typhoid fever in both male (r=-0.055) and female (r=-0.074) subjects. Also co infection was negatively correlated with malaria for male subjects (r=-0.044) while it is positively correlated with the female subjects (r=0.335). Similarly typhoid fever was negatively correlated with malaria in both male (r=-0.079) and females (r=-0.105) subjects. Conclusively, the results in this study showed that the prevalence of malaria and typhoid co-infections are low which means the no association was found between malaria and typhoid fever infections within the study area. Hence one cannot actually say that malaria may predispose to typhoid fever. Also cross reacting antigens are widely distributed in the microbial world and since there will always be repeated exposures to salmonella species in endemic regions, increased efforts should be made to find a better, more rapid, sensitive and specific clinical and cultural methods.
An estimated 50,000 Nigerian women die each year from complications of pregnancy and childbirth, accounting for 10% of global estimates of pregnancy maternal death with about 2% resulting from drug induction. This cross-sectional study sets out to evaluate the Prothrombin time test (PT), activated partial thromboplastin time test (aPTT) Erythrocyte sedimentation rate (ESR), and Platelet count (PC) of pregnant women attending antenatal clinics at Oredo Health Centre in Benin City, Edo State. A total number of 130 subjects comprising 100 pregnant women and 30 non-pregnant women were recruited for the study. Prothrombin time (PT), Activated Partial Thromboplastin Time (APTT), Platelet count and Erythrocyte Sedimentation Rate (ESR) were studied using standard manual methods. The prothrombin time (sec) of the pregnant women 1st trimester (19.12±0.77b), 2nd trimester (19.90±1.02 b) and 3rd trimester (19.66±0.56 b), activated partial thromboplastin time (sec) 1st trimester (44.02±1.17 b), 2nd trimester (47.72±1.47 b) and 3rd trimester (45.88±1.10b), Erythrocyte sedimentation rate (mm/hr) 1st trimester (24.37±3.04 a), 2nd trimester (37.83±4.53 a) and 3rd trimester (43.25±5.24 a) and platelet count (X109/L) 1st trimester (248.29±23.18a), 2nd trimester (236.33±13.84 b) and 3rd trimester (239.10±16.07 a) were significantly higher than the prothrombin time (sec) 16.48±0.81 a, activated partial thromboplastin time (sec) 36.53±1.42 a, ESR (mm/hr) 29.83±4.14 a and platelet count (X109/L) 201±9.54 an of the non-pregnant women (p<0.05). The ESR (mm/hr) of the 3rd trimester (43.25±5.24) was observed to be significantly higher than that of the 1st trimester (24.37±3.04) and 2nd trimester (37.83±4.53) (p<0.05). Our investigation showed that antibiotics in pregnancy have a deleterious effect on PT, ESR, APTT and PC studied. We recommend that pregnant women should be given due attention throughout the course and events of pregnancy to prevent or reduce the risk of thrombotic episodes and possible disseminated intravascular coagulation (DIC) with resultant better maternity/child safety and health outcome and educated on the effects of antibiotics to pregnancy.
Beta-lactamases are enzymes produced by some bacteria allow in them to provide resistance to beta-lactam antibiotics like penicillins, cephamycins, and carbapenems (Ertapenem), although carbapenems are relatively resistant to beta-lactamase. Extended Spectrum Beta-lactamase (ESBL) has the ability to hydrolyze and cause resistance to various types of the newer β-lactam antibiotics. Penicillinase is a specific type of β-lactamase, showing specificity for penicillins, again by hydrolysing the beta-lactam ring. Penicillinase-resistant beta-lactams such as methicillin were developed, but there is now widespread resistance to even these antibiotics. Currently, ESBLs are becoming a major threat for patients in the hospital, long-term care facilities, and community. These bacteria have not only caused outbreaks but have become endemic in many hospitals throughout the world. It is therefore necessary to place surveillance of antibiotics in our Society to avoid increase antibiotics resistance producing organisms. Routine monitoring of antibiotic resistance to provides data for antibiotic therapy and resistance control with information will directly affect selection of empiric therapy for urinary tract infection in pregnant women is recommended to promote good antenatal management in the health sector. The awareness of the existence of ESBL is recommended to initializes indication for the need for proper use of antibiotics and spread of multi drug resistance bacterial strains within these hospital and communities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.